Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://louisetmuq989726.eedblog.com/39237948/retaglutide-a-promising-glp-1-receptor-agonist